Send to a Friend Font Size: Increase Decrease

RO and ALNY Related Headlines

Aug 30, 2025 10:30AM Genentech and Alnylam Advance Zilebesiran Into Global Phase III Cardiovascular Outcomes Trial for People With Uncontrolled Hypertension

RO and ALNY Related Press Releases

Aug 30, 2025 10:30AM Genentech and Alnylam Advance Zilebesiran Into Global Phase III Cardiovascular Outcomes Trial for People With Uncontrolled Hypertension

RO and ALNY Related SEC Filings